Esperion Therapeutics Inc (ESPR)
Income Before Tax
-$25.20M
Quarterly · Period ending: · USD
ESPR Income Before Tax
Latest reported-$25.20Mperiod ending
Latest reported-$25.20Mperiod ending
ESPR Quarterly Pre-Tax Income (-$5.73M → -$25.20M)
Quarterly income before tax
High-resolution chart · PNG
ESPR income before tax history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Income Before Tax (USD) |
|---|---|
| -25,196,000 | |
| 63,672,000 | |
| -31,333,000 | |
| -12,725,000 | |
| -40,455,000 | |
| -21,318,000 | |
| -29,524,000 | |
| -61,925,000 | |
| 61,022,000 | |
| -56,344,000 | |
| -41,250,000 | |
| -49,935,000 | |
| -61,719,000 | |
| -55,487,000 | |
| -55,117,000 | |
| -66,324,000 | |
| -56,731,000 | |
| -65,119,000 | |
| -69,386,000 | |
| -43,668,000 | |
| -90,935,000 | |
| -104,476,000 | |
| -85,437,000 | |
| 124,611,000 | |
| -78,249,000 | |
| -61,946,000 | |
| -68,377,000 | |
| -54,221,000 | |
| 87,379,000 | |
| -60,039,000 | |
| -49,911,000 | |
| -45,730,000 | |
| -46,130,000 | |
| -37,891,000 | |
| -45,219,000 | |
| -43,337,000 | |
| -40,541,000 | |
| -28,956,000 | |
| -17,402,000 | |
| -14,035,000 | |
| -14,585,000 | |
| -13,122,000 | |
| -12,801,000 | |
| -12,395,000 | |
| -11,466,000 | |
| -9,457,000 | |
| -9,806,000 | |
| -9,238,000 | |
| -7,874,000 | |
| -9,689,446 | |
| -5,238,434 | |
| -6,921,076 | |
| -4,239,177 | |
| -2,775,356 | |
| -3,351,274 | |
| -3,166,154 | |
| -2,448,952 | |
| -6,563,000 | |
| -8,435,000 | |
| -7,406,000 | |
| -6,619,000 | |
| -6,980,000 | |
| -7,824,000 | |
| -7,303,000 | |
| -6,344,000 | |
| -6,281,000 | |
| -6,325,000 | |
| -5,981,000 | |
| -6,803,000 | |
| -11,693,000 | |
| -7,371,000 | |
| -5,725,392 |